Literature DB >> 7537540

Adenovirus-mediated gene transfer for cystic fibrosis: Part A. Safety of dose and repeat administration in the nasal epithelium. Part B. Clinical efficacy in the maxillary sinus.

M J Welsh1, J Zabner, S M Graham, A E Smith, R Moscicki, S Wadsworth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7537540     DOI： 10.1089/hum.1995.6.2-205

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  10 in total

1.  Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype.

Authors:  T E Sparer; S G Wynn; D J Clark; J M Kaplan; L M Cardoza; S C Wadsworth; A E Smith; L R Gooding
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

2.  Lack of high affinity fiber receptor activity explains the resistance of ciliated airway epithelia to adenovirus infection.

Authors:  J Zabner; P Freimuth; A Puga; A Fabrega; M J Welsh
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

3.  Viral Vectors, Animal Models, and Cellular Targets for Gene Therapy of Cystic Fibrosis Lung Disease.

Authors:  Yinghua Tang; Ziying Yan; John F Engelhardt
Journal:  Hum Gene Ther       Date:  2020-04-15       Impact factor: 5.695

4.  Apical localization of the coxsackie-adenovirus receptor by glycosyl-phosphatidylinositol modification is sufficient for adenovirus-mediated gene transfer through the apical surface of human airway epithelia.

Authors:  R W Walters; W van't Hof; S M Yi; M K Schroth; J Zabner; R G Crystal; M J Welsh
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 5.  Potential use of T cell receptor genes to modify hematopoietic stem cells for the gene therapy of cancer.

Authors:  T M Clay; M C Custer; P J Spiess; M I Nishimura
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

6.  A chimeric type 2 adenovirus vector with a type 17 fiber enhances gene transfer to human airway epithelia.

Authors:  J Zabner; M Chillon; T Grunst; T O Moninger; B L Davidson; R Gregory; D Armentano
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

7.  Adenovirus-mediated gene transfer to ciliated airway epithelia requires prolonged incubation time.

Authors:  J Zabner; B G Zeiher; E Friedman; M J Welsh
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

8.  Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis.

Authors:  J Zabner; B W Ramsey; D P Meeker; M L Aitken; R P Balfour; R L Gibson; J Launspach; R A Moscicki; S M Richards; T A Standaert
Journal:  J Clin Invest       Date:  1996-03-15       Impact factor: 14.808

Review 9.  Advances in gene therapy for cystic fibrosis lung disease.

Authors:  Ziying Yan; Paul B McCray; John F Engelhardt
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 5.121

Review 10.  Cystic Fibrosis Gene Therapy: Looking Back, Looking Forward.

Authors:  Ashley L Cooney; Paul B McCray; Patrick L Sinn
Journal:  Genes (Basel)       Date:  2018-11-07       Impact factor: 4.096
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.